These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 11990078
1. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Nowak P, Brus R, Kostrzewa RM. Pol J Pharmacol; 2001; 53(4):319-29. PubMed ID: 11990078 [Abstract] [Full Text] [Related]
2. Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum. Nowak P, Dabrowska J, Bortel A, Izabela B, Kostrzewa RM, Brus R. Neurotoxicol Teratol; 2006; 28(5):563-72. PubMed ID: 17005368 [Abstract] [Full Text] [Related]
10. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex. Maple AM, Perna MK, Parlaman JP, Stanwood GD, Brown RW. Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732 [Abstract] [Full Text] [Related]
11. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Devoto P, Flore G, Pira L, Diana M, Gessa GL. Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641 [Abstract] [Full Text] [Related]
12. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Acri JB, Thompson AC, Shippenberg T. Synapse; 2001 Mar 15; 39(4):343-50. PubMed ID: 11169785 [Abstract] [Full Text] [Related]
13. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP. Neurotox Res; 2003 Mar 15; 5(5):329-38. PubMed ID: 14715452 [Abstract] [Full Text] [Related]
18. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1988 Apr 15; 245(1):199-210. PubMed ID: 3129549 [Abstract] [Full Text] [Related]
19. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. J Pharmacol Exp Ther; 1993 Jan 15; 264(1):249-55. PubMed ID: 8093727 [Abstract] [Full Text] [Related]
20. Dissociation of the effects of amphetamine and quinpirole on dopamine release in the nucleus accumbens following behavioural sensitization: an ex vivo voltammetric study. Muscat R, Patel J, Trout SJ, Wieczorek W, Kruk ZL. Behav Pharmacol; 1993 Jan 15; 4(4):411-418. PubMed ID: 11224210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]